ZY News
Archived Headlines
- US IPO Week Ahead: Software, synthetic biology, and more in an 11 IPO week 04/16/21
- US IPO Week Ahead: Software, synthetic biology, and more in an 11 IPO week 04/16/21
- Synthetic biology company Zymergen sets terms for $401 million IPO 04/14/21
- Synthetic biology company Zymergen files for a $100 million IPO 03/23/21
Recent listings are now prime acquisition targets
Recent IPOs saw their valuations collapse in 2022, but as public investors sit on the sidelines, buyout firms and corporations are hunting for bargains amid the IPO wreckage. For companies that have gone public via IPO or SPAC merger since 2015, more than 40...read more
The IPO market's ESG craze set to continue with socks and Greek yogurt
Sock maker Bombas is the latest company preparing to ride the ESG investing wave, with the certified B Corp reportedly considering an IPO as soon as this year. It would join Greek yogurt brand Chobani (CHO) in the IPO pipeline...read more
US IPO Weekly Recap: UiPath’s billion-dollar deal leads a 12 IPO Week
12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity...read more
Synthetic biology company Zymergen prices upsized IPO at $31 high end
Zymergen, which is developing biomanufacturing technologies for materials and chemicals, raised $500 million by offering 16.1 million shares at $31, the high end of the range of $28 to $31. The company offered 2.5 million more shares than anticipated. At pricing...read more